Tokyo, May 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061493) titled 'Exploration of liver disease progression pathways and identification of novel biomarkers' on May 11.
Study Type:
Observational
Primary Sponsor:
Institute - National Institutes for Quantum Science and Technology
Condition:
Condition - Liver disease
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - To establish a scientific foundation for the development of positron emission tomography(PET) based diagnostic and therapeutic strategies for liver diseases.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Human liver samples obtained from brain dead donors, consisting of transplant ineligible livers for which consent for research use was obtained, together with accompanying clinical information.
Key exclusion criteria - Samples that do not meet the quality requirements for reliable molecular analyses
Target Size - 80
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 04 Month 22 Day
Date of IRB - 2026 Year 04 Month 22 Day
Anticipated trial start date - 2026 Year 05 Month 11 Day
Last follow-up date - 2030 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070363
Disclaimer: Curated by HT Syndication.
